Lineage Cell Therapeutics, Inc. Other Non-Current Liabilities
Lineage Cell Therapeutics, Inc. (LCTX) had Other Non-Current Liabilities of $0 as of 2023-12-31, per its 10-K filed 2024-03-07.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2024-03-07
- 2023-12-31: Other Liabilities, Noncurrent $0.00.
- 2022-12-31: Other Liabilities, Noncurrent $2.00K.
- 2021-12-31: Other Liabilities, Noncurrent $30.00K.
- 2017-09-30: Other Liabilities, Noncurrent $554.00K.
| Period end | Other Liabilities, Noncurrent | Other Liabilities, Noncurrent as first filed |
|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-07 | |
| 2022-12-31 | $2.00K 10-K · filed 2024-03-07 | |
| 2021-12-31 | $30.00K 10-K · filed 2023-03-09 | |
| 2017-09-30 | $554.00K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $9.00K 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $9.00K 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $8.00K 10-Q · filed 2017-11-09 | |
| 2015-12-31 | $8.00K 10-K · filed 2017-03-16 | |
| 2015-09-30 | $18.00K 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $30.00K 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $38.12K 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $28.00K 10-K · filed 2016-03-15 | $27.96K 10-K · filed 2015-03-11 |
| 2014-09-30 | $79.11K 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $9.86K 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $8.44K 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $195.98K 10-K · filed 2015-03-11 | |
| 2013-09-30 | $200.58K 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $201.09K 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $235.04K 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $237.50K 10-K · filed 2014-03-17 | |
| 2012-09-30 | $235.33K 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $236.88K 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $255.41K 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $258.62K 10-K · filed 2013-03-18 | |
| 2011-09-30 | $272.72K 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $297.59K 10-Q · filed 2011-08-09 | |
| 2010-12-31 | $318.29K 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |